Concepedia

Sylwia Flis

SF

19

Publications

1.2K

Citations

17

H-Index

2003

Active since

Affiliations

Narodowy Instytut Leków(Current)

Temple University

Warsaw University of Technology

Medical University of Warsaw

RWTH Aachen University

Sylwia Flis is an author at Narodowy Instytut Leków specializing in medicine, pharmacology, and cancer research.

ORCID

Top concepts

Publications per year

2003–2022

19

Publications

19

DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.

Agnieszka Gnyszka, Zenon Jastrzębski, Sylwia Flis · PubMed · 2013 · 316 citations

, , +24

Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors

Margaret Nieborowska-Skorska, Piotr Kopiński, Regina Ray et al. · Blood · 2012 · 184 citations · Full text

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells

Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans‐Ulrich Klein et al. · Blood · 2013 · 132 citations · Full text

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms

Margaret Nieborowska-Skorska, Silvia Maifrede, Yashodhara Dasgupta et al. · Blood · 2017 · 75 citations · Full text

DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells

Sylwia Flis, Agnieszka Gnyszka, Krzysztof Flis · PLoS ONE · 2014 · 50 citations · Full text

Rows per page

1–5 of 19